Many employers are weighing whether to expand health plan coverage for GLPβ1 medications to include weight loss treatment. While federal law does not require plans to cover GLPβ1s for obesity, the legal landscape around such exclusions continues to evolve. This Compliance Bulletin summarizes the key considerations and explains how employers can use tax-advantaged health accounts to help employees pay for GLPβ1 medications.










